Startseite » Forschung » Publikationen » Publikationen 2021

Publikationen 2021

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2.
Kremsner, P.G., Mann, P., Kroidl, A. et al., Wien Klin Wochenschr (2021). https://doi.org/10.1007/s00508-021-01922-y

Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients.
Rubio-Acero R, Castelletti N, Fingerle V et al., Infect Dis Ther 10, 1505–1518 (2021). https://doi.org/10.1007/s40121-021-00475-x

Distinct Immune Profiles of Exhausted Effector and Memory CD8+ T Cells in Individuals With Filarial Lymphedema.
Horn S, Borrero-Wolff D, Ritter M, Arndts K, Wiszniewsky A, Debrah L, Debrah A, Osei-Mensah J, Chachage M, Hoerauf A, Kroidl I, Layland L, Frontiers in Cellular and Infection Microbiology, Volume 11, 2021, ISSN 2235-2988. https://doi.org/10.3389/fcimb.2021.680832

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant.
Kroidl I, Mecklenburg I, Schneiderat P, Müller K, Girl P, Wölfel R, Sing A, Dangel A, Wieser A, Hoelscher M.
Euro Surveill. 2021;26(30):pii=2100673. https://doi.org/10.2807/1560-7917.ES.2021.26.30.2100673

A Dried Blood Spot Protocol for high throughput analysis of SARS-CoV-2 Serology based on the Roche Elecsys Anti-N Assay.
Beyerl J, Rubio-Acero R, Castelletti N, Paunovic I, Kroidl I, Khan, Z, Bakuli, A, Tautz A, Oft J, Hoelscher M, Wieser A, EBioMedicine, Volume 70, 2021, 103502. https://doi.org/10.1016/j.ebiom.2021.103502

Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich - One year of experience.
Rubio-Acero R, Beyerl J, Muenchhoff M, Sancho Roth M,Castelletti N, Paunovic I, Radon K, Springer B, Nagel C, Boehm B, Böhmer M, Graf A, Blum H, Stefan S, Keppler O, Osterman A, Khan Z, Hölscher M, Wieser A,
Science of The Total Environment, Volume 797, 2021, 149031, ISSN 0048-9697. https://doi.org/10.1016/j.scitotenv.2021.149031

Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
Brand I, Gilberg L, Bruger J, Garí M, Wieser A, Eser TM, Frese J, Ahmed MIM, Rubio-Acero R, Guggenbuehl Noller JM, Castelletti N, Diekmannshemke J, Thiesbrummel S, Huynh D, Winter S, Kroidl I, Fuchs C, Hoelscher M, Roider J, Kobold S, Pritsch M, Geldmacher C, Front Immunol. 2021 May 20;12:688436. doi: https://doi.org/10.3389/fimmu.2021.688436. PMID: 34093595; PMCID: PMC8173205.

Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis.
Brändle SM, Cerina M, Weber S, Held K, Menke AF, Alcalá C, Gebert D, Herrmann AM, Pellkofer H, Gerdes LA, Bittner S, Leypoldt F, Teegen B, Komorowski L, Kümpfel T, Hohlfeld R, Meuth SG, Casanova B, Melzer N, Beltrán E, Dornmair K. Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):e1916337118. https://doi.org/10.1073/pnas.1916337118

HIV DNA reservoir and elevated PD-1 expression of CD4 T-cell subsets particularly persist in the terminal ileum of HIV-positive patients despite cART.
Horn C, Augustin M, Ercanoglu MS, Heger E, Knops E, Bondet V, Duffy D, Chon SH, Nierhoff D, Oette M, Schäfer H, Vivaldi C, Held K, Anderson J, Geldmacher C, Suárez I, Rybniker J, Klein F, Fätkenheuer G, Müller-Trutwin M, Lehmann C.
HIV Med. 2021 May;22(5):397-408. https://doi.org/10.1111/hiv.13031. Epub 2021 Jan 9.

Flow cytometric analysis of cell lineage and immune activation markers using minimal amounts of human whole blood-Field method for remote settings.
Horn S, Ahmed MIM, Geldmacher C, Marandu TF, Osei-Mensah J, Debrah A, Layland LE, Hoerauf A, Kroidl I.
J Immunol Methods. 2021 Apr;491:112989. https://doi.org/10.1016/j.jim.2021.112989. Epub 2021 Feb 9.

CD34T+ Humanized Mouse Model to Study Mucosal HIV-1 Transmission and Prevention.
Vanshylla K, Held K, Eser TM, Gruell H, Kleipass F, Stumpf R, Jain K, Weiland D, Münch J, Grüttner B, Geldmacher C, Klein F.
Vaccines (Basel). 2021 Feb 27;9(3):198. https://doi.org/10.3390/vaccines9030198

Serological Protection 5-6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes.
Idoko OT, Domingo C, Tapia MD, Sow SO, Geldmacher C, Saathoff E, Kampmann B.
Front Immunol. 2020 Oct 8;11:577751. https://doi.org/10.3389/fimmu.2020.577751. eCollection 2020.

From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany).
Radon K, Bakuli A, Puetz P, Le Gleut R, Guggenbühl Noller JM, Olbrich L, Saathoff E, Gari M, Schaelte Y, Frahnow T, Woelfel R, Pritsch M, Rothe C, Pletschette M, Rubio-Acero R, Beyerl J, Metaxa D, Forster F, Thiel V, Castelletti N, Riess F, Diefenbach M, Froeschl G, Bruger JM, Winter S, Frese J, Puchinger K, Brand I, Kroidl I, Wieser A, Hoelscher M, Hasenauer J, Fuchs C, KoCo19 study group.
BMC Infect. Dis. 2021 Sep 8;21(1):925. doi: 10.1186/s12879-021-06589-4.


Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.
Pritsch M, Radon K, Bakuli A, Le Gleut R, Olbrich L, Guggenbühl Noller JM, Saathoff E, Castelletti N, Garí M, Pütz P, Schälte Y, Frahnow T, Wölfel R, Rothe C, Pletschette M, Metaxa D, Forster F, Thiel V, Rieß F, Diefenbach MN, Fröschl G, Bruger J, Winter S, Frese J, Puchinger K, Brand I, Kroidl I, Hasenauer J, Fuchs C, Wieser A, Hoelscher M, on behalf of the KoCo19 study group.
International Journal of Environmental Research and Public Health. 2021; 18(7):3572. https://doi.org/10.3390/ijerph18073572

A Serology Strategy for Epidemiological Studies Based on the Comparison of the Performance of Seven Different Test Systems - The Representative COVID-19 Cohort Munich.
Laura Olbrich, Noemi Castelletti, Yannik Schälte, Mercè Garí, Peter Pütz, Abhishek Bakuli, Michael Pritsch, Inge Kroidl, Elmar Saathoff, Jessica Michelle Guggenbuehl Noller, Volker Fingerle, Ronan Le Gleut, Leonard Gilberg, Isabel Brand, Philine Falk, Alisa Markgraf, Flora Deák, Friedrich Riess, Max Diefenbach, Tabea Eser, Franz Weinauer, Silke Martin, Ernst-Markus Quenzel, Marc Becker, Jürgen Durner, Philipp Girl, Katharina Müller, Katja Radon, Christiane Fuchs, Roman Wölfel, Jan Hasenauer, Michael Hoelscher, Andreas Wieser.
Available at medRxiv 2021.01.13.21249735; doi: https://doi.org/10.1101/2021.01.13.21249735  

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial. Aldrich, C., Leroux-Roels, I., Huang, K. B., Bica, M. A., Loeliger, E., Schoenborn-Kellenberger, O., Walz, L., Leroux-Roels, G., von Sonnenburg, F., & Oostvogels, L. Vaccine. 2021; 39(8), 1310–1318. https://doi.org/10.1016/j.vaccine.2020.12.070

A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay. Beyerl, J., Rubio-Acero, R., Castelletti, N., Paunovic, I., Kroidl, I., Khan, Z.N., Bakuli, A., Tautz, A., Oft, J., Hoelscher, M., Wieser, A. EBioMedicine. 2021; 70, 103502https://doi.org/10.1016/j.ebiom.2021.103502